一种特定于疾病的iPS细胞资源,用于研究罕见和难治疾病
Megumu K Saito1, Mitsujiro Osawa2, Nao Tsuchida3
1Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, 6068507, Japan. msaito@cira.kyoto-u.ac.jp.
Inflammation and regeneration
|September 8, 2023
概括
研究人员从患有罕见难治性疾病的患者中建立了1532个诱导多能干细胞 (iPSC) 线. 这些宝贵的iPSC资源现在可用于加速罕见疾病研究和药物发现.
科学领域:
- 干细胞生物学 干细胞生物学
- 遗传学 是一个遗传学.
- 罕见疾病 罕见疾病
背景情况:
- 疾病特异性诱导多能干细胞 (iPSC) 对于研究罕见疾病至关重要.
- 从患者那里建立和储存iPSC可以克服罕见疾病研究的资源限制.
- 这项研究旨在扩大来自日本难治性疾病患者的iPSC存储库.
研究的目的:
- 为了全面建立和表征诱导多能干细胞 (iPSCs) 来自患有指定难治性疾病的患者.
- 为研究界创造一个有价值的资源,以促进罕见疾病研究.
- 为了评估新生成的iPSC线路的特性.
主要方法:
- 招募患有指定难治疾病的患者,并采集血液样本.
- 使用情节性方法建立iPSC.
- 将已建立的iPSC克隆存入细胞银行以使其更容易获得.
主要成果:
- 在139种不同的难治性疾病中,成功地从259名患者中建立了1532个iPSC克隆.
- 在不同年龄和性别之间,iPSC的建立效率是一致的.
- 所有iPSC克隆都表达了关键多能性标志物OCT3/4和NANOG,证实了它们的干细胞身份.
结论:
- 新成立的iPSC线路对研究人员来说是一个重要的,易于获得的资源.
- 这些iPSC将有助于病理分析,诊断和开发罕见难治性疾病的治疗策略.
- 该计划通过提供关键细胞模型来增强罕见疾病研究的全球能力.
相关概念视频
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K


